MEKLIT ZETAWOS: Open Payments
NPI 1528305372 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,645 in 91 payments from 16 companies in 2025. Trend: 2023 $1,523 · 2024 $1,549 · 2025 $1,645
Food & beverage: $1,465Education: $180
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 25 | $404 |
| ABBVIE INC. | 17 | $328 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $213 |
| Lilly USA, LLC | 6 | $150 |
| Aimmune Therapeutics, Inc. | 5 | $117 |
| Regeneron Healthcare Solutions, Inc. | 4 | $72 |
| GENZYME CORPORATION | 3 | $66 |
| PFIZER INC. | 4 | $58 |
| Celltrion USA Inc. | 3 | $56 |
| Intercept Pharmaceuticals, Inc. | 3 | $46 |
Products named: TREMFYA, ENTYVIO, SKYRIZI, OMVOH, DUPIXENT, RINVOQ, ZENPEP, VEGZELMA.
Industry payments across KS — which companies pay providers there.
